Specifically concerning human gastric cells, Zhou et al. [50] reported the effects of vitexin upon the gastric AGS cells with KRAS mutation, being also found to inhibit xenograft tumour growth and liver metastasis in vivo [50]. The gene discussed is KRAS; the disease is neoplasm.